Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 28


Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Gras Navarro A, Björklund AT, Chekenya M.

Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015. Review.


NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.

Gras Navarro A, Kmiecik J, Leiss L, Zelkowski M, Engelsen A, Bruserud Ø, Zimmer J, Enger PØ, Chekenya M.

J Immunol. 2014 Dec 15;193(12):6192-206. doi: 10.4049/jimmunol.1400859. Epub 2014 Nov 7.


Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma.

Rygh CB, Wang J, Thuen M, Gras Navarro A, Huuse EM, Thorsen F, Poli A, Zimmer J, Haraldseth O, Lie SA, Enger PØ, Chekenya M.

PLoS One. 2014 Sep 30;9(9):e108414. doi: 10.1371/journal.pone.0108414. eCollection 2014.


Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma.

Kmiecik J, Gras Navarro A, Poli A, Planagumà JP, Zimmer J, Chekenya M.

Oncoimmunology. 2014 Jan 1;3(1):e27185.


Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model.

Skeie BS, Wang J, Dodoo E, Heggdal JI, Grønli J, Sleire L, Bragstad S, Ganz JC, Chekenya M, Mørk S, Pedersen PH, Enger PØ.

Biomed Res Int. 2013;2013:139674. doi: 10.1155/2013/139674. Epub 2013 Nov 10.


Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.

Poli A, Wang J, Domingues O, Planagumà J, Yan T, Rygh CB, Skaftnesmo KO, Thorsen F, McCormack E, Hentges F, Pedersen PH, Zimmer J, Enger PØ, Chekenya M.

Oncotarget. 2013 Sep;4(9):1527-46.


Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours.

Kmiecik J, Zimmer J, Chekenya M.

J Neurooncol. 2014 Jan;116(1):1-9. doi: 10.1007/s11060-013-1265-5. Epub 2013 Oct 2. Review.


Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.

Kmiecik J, Poli A, Brons NH, Waha A, Eide GE, Enger PØ, Zimmer J, Chekenya M.

J Neuroimmunol. 2013 Nov 15;264(1-2):71-83. doi: 10.1016/j.jneuroim.2013.08.013. Epub 2013 Aug 31.


NK cells in central nervous system disorders.

Poli A, Kmiecik J, Domingues O, Hentges F, Bléry M, Chekenya M, Boucraut J, Zimmer J.

J Immunol. 2013 Jun 1;190(11):5355-62. doi: 10.4049/jimmunol.1203401. Review.


Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation.

Moen I, Jevne C, Wang J, Kalland KH, Chekenya M, Akslen LA, Sleire L, Enger PØ, Reed RK, Øyan AM, Stuhr LE.

BMC Cancer. 2012 Jan 17;12:21. doi: 10.1186/1471-2407-12-21.


Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M.

Acta Neuropathol. 2011 Oct;122(4):495-510. doi: 10.1007/s00401-011-0867-2. Epub 2011 Aug 24.


Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planagumà J, Reed RK, Bjerkvig R, Miletic H, Enger PØ, Rygh CB, Chekenya M.

PLoS One. 2011;6(7):e23062. doi: 10.1371/journal.pone.0023062. Epub 2011 Jul 29.


3D image texture analysis of simulated and real-world vascular trees.

Kociński M, Klepaczko A, Materka A, Chekenya M, Lundervold A.

Comput Methods Programs Biomed. 2012 Aug;107(2):140-54. doi: 10.1016/j.cmpb.2011.06.004. Epub 2011 Jul 30.


Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence-activated cell sorting.

Poli A, Brons NH, Ammerlaan W, Michel T, Hentges F, Chekenya M, Zimmer J.

Immunology. 2010 Nov;131(3):386-94. doi: 10.1111/j.1365-2567.2010.03312.x.


Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.

Krakstad C, Chekenya M.

Mol Cancer. 2010 Jun 1;9:135. doi: 10.1186/1476-4598-9-135. Review.


A reproducible brain tumour model established from human glioblastoma biopsies.

Wang J, Miletic H, Sakariassen PØ, Huszthy PC, Jacobsen H, Brekkå N, Li X, Zhao P, Mørk S, Chekenya M, Bjerkvig R, Enger PØ.

BMC Cancer. 2009 Dec 29;9:465. doi: 10.1186/1471-2407-9-465.


Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model.

Moen I, Øyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, Sakariassen PØ, Reed RK, Stuhr LE.

PLoS One. 2009 Jul 28;4(7):e6381. doi: 10.1371/journal.pone.0006381.


Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

Verhoeff JJ, Stalpers LJ, Van Noorden CJ, Troost D, Ramkema MD, van Bree C, Song JY, Donker M, Chekenya M, Vandertop WP, Richel DJ, van Furth WR.

Cancer Lett. 2009 Nov 18;285(1):39-45. doi: 10.1016/j.canlet.2009.04.038. Epub 2009 May 26.


The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.

Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB.

Oncogene. 2008 Sep 4;27(39):5182-94. doi: 10.1038/onc.2008.157. Epub 2008 May 12.


NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation.

Joo NE, Watanabe T, Chen C, Chekenya M, Stallcup WB, Kapila YL.

Cell Death Differ. 2008 May;15(5):899-907. doi: 10.1038/cdd.2008.22. Epub 2008 Feb 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk